U.S. Specialty Injectable Generics Market Supply-Demand, Production Cost and Share Analysis
U.S. Specialty Injectable Generics Market Summary The U.S. specialty injectable generics market size was estimated at USD 19.23 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 8.33% from 2023 to 2030. The demand for specialty generic drugs has been increasing significantly due to the rising prevalence of target diseases such as cancer, hepatitis C, multiple sclerosis, and other chronic illnesses. Additionally, the market is benefitting from the growing number of approvals for injectable generic drugs. For example, the U.S. FDA highlighted Generic Drug Approvals in 2023, which included Midazolam in 0.9% Sodium Chloride Injection, Aggrastat (Tirofiban Hydrochloride) Injection, Cysteine Hydrochloride Injection, and Morphine Sulfate Injection, reflecting the expanding product portfolio in this field. Furthermore, growth in this sector can be attributed to enhanced accessibility and affordability of injectables, providing patients with sa...